The $4.25 Million Pill: Public Science, Private Profit, and Pricey Pills

Brothers and sisters, gather ’round the altar of irony where we find our taxpayer dollars funding drug research like manna from a public lab, only for the private sector to charge us $4.25 million a pill for the privilege of survival. It seems we’ve turned public good into a golden calf of profit, where sacred dollars offered in good faith find themselves on a pharmacy shelf with a price tag only the angels can afford.

Is this what stewardship looks like? We bake a cake with ingredients from our own pantry, then pay $50 a slice just to enjoy what was ours to begin with. Perhaps it’s time we reconsider who truly deserves that spot in the front pew—charity or commerce—and whether public funding ought to serve the public purse rather than padding the pockets of a few blessed businessmen. Peace be with you, unless of course, you’re the one holding the receipt.